Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover advanced chiral pyridoxal catalysts for asymmetric aldol reactions. Enable cost reduction in fine chemical manufacturing with scalable, metal-free synthesis routes.
Patent CN113754694B reveals a novel chiral bicyclic imidazole catalyst method for Remdesivir. Achieve high-purity API intermediates with reduced manufacturing costs.
Patent CN110526944A reveals high-efficiency Ru catalyst for asymmetric transfer hydrogenation, offering cost reduction and supply reliability.
Patent CN116514707A discloses manganese-catalyzed asymmetric hydrogenation for high-purity pharmaceutical intermediates with significant cost and supply chain advantages.
Patent CN108409802B details a high-efficiency iridium-catalyzed asymmetric hydrogenation route for producing high-purity chiral ferrocene amines with significant cost advantages.
Novel Rh(I) catalyzed asymmetric B-H insertion for high-purity chiral boranes. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel asymmetric synthesis of chiral dihydrofurans via squaric acid catalysis. High enantioselectivity and mild conditions for API manufacturing.
Patent CN116947580A enables high-yield axially chiral compound production. Offers supply chain reliability and cost reduction in fine chemical manufacturing for global partners.
Patent CN103214520B reveals ionic liquid supported chiral ligands enabling efficient catalyst recovery and high enantioselectivity for pharmaceutical intermediates manufacturing.
Patent CN113461589A details a novel one-step asymmetric Friedel-Crafts reaction yielding high-purity chiral indoleamines with significant cost reduction potential.
Patent CN112811996B details a metal-free catalytic method for synthesizing chiral ketones with high enantioselectivity, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN115260205A reveals novel bispyrene-doped extended porphyrins with high asymmetry factors. Discover cost-effective synthesis for OLED and chiral catalysis applications.
Novel biomimetic catalytic transfer hydrogenation for aprepitant intermediates. High yield, mild conditions, cost-effective manufacturing solution.
Patent CN111825508A details asymmetric hydrogenation for high-purity chiral amines, offering cost-effective pharma intermediate manufacturing solutions.
Patent CN115073399A reveals a low-cost bifunctional catalyst for high-yield chiral beta-butyrolactone production, offering significant supply chain advantages.
Novel Ru-phosphine-nitrogen complexes enable efficient ketone reduction. Enhances supply chain reliability and reduces manufacturing costs for chiral intermediates.
Patent CN112279743B details a novel iridium-catalyzed asymmetric hydrogenation method for chiral alpha-amino acid esters, offering high enantioselectivity and industrial scalability for pharmaceutical intermediates.
Patent CN105330608A reveals high-ee urazole synthesis. Enables cost reduction in chiral catalyst manufacturing and reliable supply chain for pharma intermediates.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.
Patent CN103087105B details high-efficiency asymmetric hydrogenation for chiral beta-aryl amides, offering significant supply chain and cost advantages for pharmaceutical manufacturing.